Indofarma Tbk. vs Maskapai Reasuransi Indonesia Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Maskapai Reasuransi Indonesia Tbk. trades at Rp920 (market cap 476.37B). The key difference: Maskapai Reasuransi Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| INAF | MREI | |
|---|---|---|
Market Cap | 390.51B | 476.37B |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Maskapai Reasuransi Indonesia Tbk (the Company) was established on 4th June 1953 based on Notarial Deed No. 15 of Anton Frederik Schut a substitute of Meester Karel Esuard Krijgsman, notary in Jakarta.In 1998 PT. Dharmala Sakti Sejahtera became one of Marein’s major shareholders, besides AJB Bumiputera 1912, and as the result the company was able to increase its paid up capital to Rp 3,002,500,000.
Read more on MREI →